|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD 69.24 Million
|
|
Market Size (2030)
|
USD 103.70 Million
|
|
CAGR (2025-2030)
|
6.89%
|
|
Fastest Growing Segment
|
Molecular Testing
|
|
Largest Market
|
North India
|
Market Overview
India Genetic Testing Market was valued at USD 69.24 Million in 2024 and is anticipated to reach USD 103.70 Million by 2030, with a CAGR of 6.89% during 2025-2030. The India Genetic Testing
Market is primarily driven by several key factors. Increasing awareness and
acceptance of genetic testing among the population for diagnosing various
genetic disorders and diseases contribute significantly to market growth. Advancements
in technology, such as next-generation sequencing and PCR techniques, have
enhanced the accuracy and efficiency of genetic testing, further fueling market
expansion. The rising prevalence of chronic diseases and genetic disorders in
India has also stimulated the demand for genetic testing services. Government
initiatives and investments in healthcare infrastructure, coupled with a
growing focus on personalized medicine, are fostering market growth. Overall,
these factors collectively drive the India Genetic Testing Market toward
sustained progression.
Key Market Drivers
Increasing Awareness and Acceptance
One of the primary drivers of the India Genetic
Testing Market is the rising awareness and acceptance of genetic testing among
the population. Over the years, there has been a significant increase in public
awareness regarding the role of genetic testing in diagnosing various genetic
disorders and diseases. This increased awareness has been facilitated by
educational campaigns, media coverage, and growing discussions within the
medical community about the importance of genetic testing for disease
prevention, early diagnosis, and personalized treatment approaches. As people
become more knowledgeable about the benefits of genetic testing, they are more
likely to seek out these services, thereby driving market growth.
Technological Advancements
Another key driver of the India Genetic Testing
Market is the continuous advancements in technology, particularly in the field
of molecular biology and genetics. Technologies such as next-generation
sequencing (NGS), polymerase chain reaction (PCR), and microarray analysis have
revolutionized the landscape of genetic testing, enabling faster, more
accurate, and cost-effective testing methods. These technological innovations
have expanded the scope of genetic testing, allowing for the simultaneous
analysis of multiple genes or genomic regions, which is particularly beneficial
for complex genetic disorders. As technology continues to evolve, genetic
testing methods are becoming more sophisticated, driving market growth and
adoption.
Prevalence of Genetic Disorders
The increasing prevalence of genetic disorders and
chronic diseases in India is another significant driver of the genetic testing
market. Genetic disorders encompass a wide range of conditions, including rare
genetic diseases, hereditary cancers, and chromosomal abnormalities, which
collectively contribute to the burden of disease in the population. With the
growing incidence of genetic disorders, there is a corresponding increase in
the demand for genetic testing services for early detection, risk assessment,
and genetic counseling. This prevalence-driven demand for genetic testing is
expected to fuel market growth as healthcare providers and policymakers
prioritize the management and prevention of genetic diseases.
Government Initiatives and Policies
Government initiatives and policies aimed at
promoting healthcare infrastructure and improving access to genetic testing
services are also driving the India Genetic Testing Market. In recent years,
the Indian government has launched various programs and schemes to enhance
healthcare delivery, including initiatives focused on genetic screening,
counseling, and testing services. These efforts aim to address the unmet needs
of underserved populations, improve healthcare equity, and reduce the burden of
genetic diseases in the country. By investing in genetic testing infrastructure
and subsidizing testing costs, the government is playing a crucial role in
driving market expansion and facilitating wider adoption of genetic testing
services across India. For instance, in February 2024, the Genetic Research
Centre (GRC) at ICMR's National Institute of Reproductive and Child Health
(ICMR-NIRRCH) in Mumbai has achieved a notable milestone by becoming
Maharashtra's inaugural government facility to provide complimentary genetic
testing and counseling services for rare diseases. Currently, the center
attends to referrals originating from municipal corporations, government
medical colleges, and hospitals within Mumbai's vicinity, as well as rural
communities spanning Maharashtra. In an official statement, the institute
emphasized its capacity to deliver comprehensive assistance through genetic
counseling and testing to individuals grappling with rare diseases.
Personalized Medicine and Targeted Therapies
The growing focus on personalized medicine and
targeted therapies is driving the demand for genetic testing in India.
Personalized medicine aims to tailor medical treatments to individual patients
based on their genetic makeup, lifestyle factors, and environmental influences.
Genetic testing plays a central role in personalized medicine by providing
insights into an individual's genetic predispositions, drug responses, and
disease risks, thereby enabling more precise diagnosis and treatment decisions.
As healthcare providers increasingly recognize the potential of personalized
medicine to improve patient outcomes and reduce healthcare costs, the demand
for genetic testing is expected to rise, driving market growth in India.
Download Free Sample Report
Key Market Challenges
Cost and Affordability
One of the primary challenges hindering the growth
of the India Genetic Testing Market is the cost and affordability of genetic
testing services. Despite technological advancements that have led to cost
reductions in genetic testing, many tests remain relatively expensive, making
them unaffordable for a significant portion of the population, particularly in
low- and middle-income segments. The high cost of genetic testing can act as a
barrier to access, limiting the uptake of testing services among individuals
who may benefit from them. The lack of reimbursement policies and inadequate
insurance coverage for genetic testing further exacerbate the affordability
issue, placing a financial burden on patients who seek testing out-of-pocket.
Addressing the cost and affordability of genetic testing is crucial for
ensuring equitable access to testing services and maximizing their public
health impact in India.
Limited Access in Rural and Underserved Areas
Access to genetic testing services is
disproportionately limited in rural and underserved areas of India, posing a
significant challenge to equitable healthcare delivery. The majority of genetic
testing facilities are concentrated in urban centers, leaving rural populations
with limited access to testing services due to geographical barriers,
infrastructure constraints, and healthcare workforce shortages. Lack of
awareness, inadequate transportation networks, and socioeconomic disparities
further exacerbate the access gap, preventing many individuals from seeking
genetic testing or receiving timely follow-up care. Addressing the inequities
in access to genetic testing requires a multifaceted approach that includes the
expansion of testing infrastructure, telemedicine initiatives, community
outreach programs, and targeted interventions to overcome barriers specific to
rural and underserved populations. By improving access to genetic testing
services, India can ensure that all individuals, regardless of their geographic
location or socioeconomic status, have the opportunity to benefit from advances
in genomic medicine.
Key Market Trends
Expansion of Healthcare Infrastructure
The expansion of healthcare infrastructure,
including the establishment of diagnostic laboratories and genetic counseling
centers, is facilitating the growth of the genetic testing market in India. In
recent years, there has been a significant increase in the number of healthcare
facilities offering genetic testing services across the country, driven by both
public and private investments in healthcare infrastructure. This expansion has
improved access to genetic testing services for individuals residing in urban
as well as rural areas, thereby contributing to market growth. As healthcare infrastructure
continues to expand and become more accessible, the demand for genetic testing
is expected to increase further, driving market expansion.
Rising Healthcare Expenditure
The rising healthcare expenditure in India is also
contributing to the growth of the genetic testing market. As the Indian economy
continues to grow and household incomes rise, there is a corresponding increase
in healthcare spending by individuals and families. This increase in healthcare
expenditure is fueling demand for advanced medical services, including genetic
testing, as people prioritize preventive healthcare and early disease
detection. The growing availability of health insurance coverage for genetic
testing and related services is further driving market growth by making these
services more affordable and accessible to a larger segment of the population.
Segmental Insights
Type Insights
Based on the Type, Molecular
Testing stands out as the dominant force, showcasing remarkable growth and
widespread adoption. Molecular testing encompasses a diverse array of
techniques that analyze nucleic acids (DNA and RNA) to detect genetic
variations, mutations, and biomarkers associated with various diseases and
conditions. This dominance can be attributed to several factors, including
technological advancements, clinical utility, and the expanding scope of
applications across medical specialties. Molecular testing has revolutionized
the field of genetics by offering highly sensitive, specific, and efficient
methods for genetic analysis. Techniques such as polymerase chain reaction
(PCR), next-generation sequencing (NGS), and fluorescence in situ hybridization
(FISH) have significantly enhanced the accuracy and throughput of genetic
testing, enabling the detection of genetic alterations with unprecedented
precision. These technological advancements have expanded the capabilities of
molecular testing beyond traditional cytogenetic and biochemical methods,
allowing for comprehensive analysis of genetic material at the molecular level.
The clinical utility of
molecular testing across a wide range of medical specialties has further
propelled its dominance in the India Genetic Testing Market. Molecular testing
plays a pivotal role in the diagnosis, prognosis, and management of genetic
disorders, infectious diseases, cancer, and pharmacogenomics. In the realm of
genetic disorders, molecular testing offers rapid and accurate diagnosis of
inherited conditions, such as cystic fibrosis, thalassemia, and Duchenne
muscular dystrophy, facilitating early intervention and personalized treatment
strategies. In infectious disease diagnostics, molecular testing enables the
rapid detection and identification of pathogens, including bacteria, viruses,
and parasites, leading to timely initiation of appropriate therapy and
infection control measures. In oncology, molecular testing has revolutionized
cancer care by guiding targeted therapies, predicting treatment response, and
monitoring disease progression through the detection of specific mutations and
molecular biomarkers.
Application Insights
Based on Application, Reproductive
Cancer Screening emerges as a dominant force, reflecting its critical role in
preventive healthcare and disease management. Reproductive cancer screening
encompasses a range of genetic tests aimed at assessing an individual's risk of
developing hereditary cancers affecting the reproductive organs, such as
breast, ovarian, uterine, and prostate cancers. Several factors contribute to
the dominance of reproductive cancer screening in the genetic testing
landscape, including the high prevalence and mortality rates of reproductive
cancers in India, the increasing awareness and emphasis on cancer prevention,
and the availability of targeted screening programs and interventions.
Breast cancer, in
particular, poses a significant public health challenge in India, with rising
incidence rates and a high disease burden among women. Genetic testing for
hereditary breast cancer susceptibility genes, such as BRCA1 and BRCA2, plays a
crucial role in identifying individuals at increased risk of developing breast
and ovarian cancers. These genetic tests enable early detection of pathogenic
mutations associated with hereditary breast cancer syndromes, allowing for
personalized risk assessment, enhanced surveillance, and preventive measures,
such as risk-reducing surgeries or intensified screening protocols. Similarly,
ovarian cancer represents another major reproductive cancer burden in India,
with limited options for early detection and effective treatment. Genetic
testing for hereditary ovarian cancer syndromes, such as Lynch syndrome and
hereditary breast and ovarian cancer (HBOC) syndrome, helps identify
individuals with an elevated risk of developing ovarian cancer due to inherited
genetic mutations. Early identification of high-risk individuals through
genetic testing enables targeted interventions, such as risk-reducing
surgeries, chemoprevention, or close surveillance with imaging and biomarker
monitoring, thereby improving clinical outcomes and reducing cancer-related
morbidity and mortality.
Download Free Sample Report
Regional Insights
North India is dominating the India Genetic Testing
Market over other regions, there are several factors contributing to its
prominence and significant presence in the genetic testing landscape. These
factors include the concentration of healthcare infrastructure, research
institutions, economic development, and population demographics, which
collectively contribute to North India's strong position in the genetic testing
market.
One of the primary reasons for North India's
prominence in the genetic testing market is the concentration of major
metropolitan areas and urban centers with robust healthcare infrastructure. The
National Capital Region (NCR), comprising cities like Delhi, Gurugram, Noida,
and Ghaziabad, serves as a hub for healthcare services, research, and
innovation. Delhi, as the capital city, is home to premier medical
institutions, government hospitals, and research centers, driving advancements
in medical genetics and genetic testing services. The presence of leading
hospitals, diagnostic laboratories, and academic medical centers in Delhi and
its surrounding areas facilitates access to genetic testing services for a
large population base. Delhi, located in the southwestern part of the NCR, has
emerged as a key player in the genetic testing market, owing to its rapid
economic growth and development. The city is home to a burgeoning healthcare
sector, with state-of-the-art hospitals, specialty clinics, and diagnostic
centers offering advanced genetic testing services. Delhi's strategic location
and connectivity to other parts of India and the world make it an attractive
destination for healthcare investments and collaborations, further bolstering
its position in the genetic testing market.
Recent Developments
- In May 2024, a startup
headquartered in Pune, iMeUsWe, has unveiled its DNA testing services in
collaboration with MapMyGenome, boasting over 23 years of expertise in
genomics. The DNA testing service aims to offer comprehensive insights into
crucial aspects of health, wellness, and ancestry. It includes expert genetic counselling
as a complimentary addition, tailored to provide insightful guidance aligned
with individual goals, lifestyle choices, family health history, and genetic
outcomes.
Key Market Players
- MedGenome Labs Limited
- Strand Life Sciences Pvt Ltd.
- Centogene India Private
Limited
- Eurofins Genomics India Pvt
Ltd.
- Mapmygenome India Limited
- Clevergene Biocorp Private
Limited
- LifeCell International Pvt.
Ltd.
- Genes2Me Pvt. Ltd.
- GeneTech India Private Limited
- DNA Forensics Laboratory Pvt.
Ltd.
|
By Type
|
By Application
|
By Region
|
- Cytogenetic Testing
- Biochemical Testing
- Molecular Testing
|
- Reproductive Cancer Screening
- Ancestry Testing
- Predictive and Pre-symptomatic Testing
- Others
|
|
Report Scope:
In this report, the India Genetic Testing Market has
been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- India Genetic Testing Market, By Type:
o Cytogenetic Testing
o Biochemical Testing
o Molecular Testing
- India Genetic Testing Market, By Application:
o Reproductive Cancer
Screening
o Ancestry Testing
o Predictive and Pre-symptomatic
Testing
o Others
- India Genetic Testing Market, By Region:
o North
o South
o West
o East
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the India Genetic Testing Market.
Available Customizations:
India Genetic Testing Market report with the
given market data, TechSci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
India Genetic Testing Market is an upcoming report
to be released soon. If you wish an early delivery of this report or want to
confirm the date of release, please contact us at [email protected]